Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline

Study Title
A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline
Teva Identifier
TVP1012-PK-10002
ClinicalTrials.gov Identifier
NCT01879748
Study Status
Completed
Trial Condition(s)
Parkinson's Disease
Interventions
Drug: Rasagiline | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
20 Years to 50 Years
Trial Duration
06/01/2013 - 11/01/2013
Phase
Phase 1

Study Type

Interventional